Fundz

Iovance Biotherapeutics Appoints Noah Berkowitz as Chief Medical Officer

PUBLIC · IOVAOct 02, 2026

Position

Chief Medical Officer

Company

Iovance Biotherapeutics

Noah Berkowitz
San CarlosBiotechnologyHealth CareTherapeutics

Description

Iovance Biotherapeutics has appointed Noah Berkowitz as Chief Medical Officer. Dr. Berkowitz brings extensive experience in drug development and regulatory approvals to support Iovance's TIL platform.

Company Information

Company

Iovance Biotherapeutics

Location

San Carlos, California, United States

About

Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, that may extend and improve life for patients with cancer.

Fundz sees it the moment Iovance Biotherapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Dan
Likely contact at this company
••••••••@••••••••

See Dan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Iovance Biotherapeutics's next move

Learn about Strategic plan

Iovance Biotherapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.